Task 1: Topic selection
Pathway Analysis
Task 2: Literature review
Comprehensive expression profiling of tumor cell lines identifies molecular signatures of melanoma progression (PLos ONE July 2007 issue 1-13)
The incidence of melanoma is increasing at one of the highest rates for any form of cancer in the world. The key to improved survival in all affected individual remains early diagnosis and treatment. Thus, the identification of molecular signatures of melanoma progression which can be used to develop accurate prognostic markers and effective targeted therapies. In order to gain an improved understanding of the molecular basis of melanoma progression, we have compared gene expression profiling data from melanoma cell lines representing discrete stages of malignant. These clustering identified two distinct molecular subclasses of melanoma segregating aggressive metastatic tumor cell line from less aggressive primary tumor cell lines. Further analysis of expression signature associated with melanoma progression using functional annotation categorized these transcripts into three classes of genes: 1. Up-regulation of activator of cell cycle progression, DNA replication and repair. 2. Loss of genes associated with cellular adhesion and melanocyte differentiation, 3. Up-regulation of genes associated with resistance to apoptosis.
Inclusion, the gene expression profiling studies of melanoma cell lines from varying stages of malignant progression and primary human melanocytes have identified several important melanoma signatures. It is expected that the novel melanoma progression associated genes identified in this study will provide new insights into the molecular defects associated with this malignancy and ultimately pave the way for the development of new melanoma biomarkers and novel targeted therapies.
Task 3: Research Question and Objectives
Any other subclasses of gene associated with the melanoma progression from primary to metastasis?
Objectives
To find the potential genes from Entrez and other literature and then test them by microarray and pathway analysis, in order to demonstrate the relationship between the group of genes and metastatic melanoma.
Task 4: Methods
A number of studies have identified multiple biomarkers for metastatic progression. Theses studies consider only direct comparison between metastatic and non-metastatic classes of samples. To apply this concept in cancer gene expression studies, my analysis utilize a combination of microarray and pathway analysis to test the relation between different groups of primary and metastatic cancer.
Many studies indicate that regardless of the tissue of origin, all metastatic tumors share a number of common feature related to change in basic energy metabolism, cell adhesion/cytoskeleton remodeling, antigen presentation and cell cycle regulation. There are several biological pathways differentially expressed between primary solid and metastatic tumors including oxidative phosphorylation, ubiquinone metabolism, cytoskeleton remodeling_Keratin filaments and cell adhesion_ECM remodeling. By Entrez search, we will find the information about the genes involve into the particular biological pathways including GEO number. By the GEO search, we can download the microarray data represented the particular genes.
All the microarray data of the various genes can be input into the Carmaweb to perform hierarchical clustering and renders a heat map of the expression profiles.
We can use another bioinformatics tool to analyze the interaction prediction of different biological pathway which is Search Tool for the Retrieval of Interacting Genes/Proteins (STRING)
Subclass of genes | Gene Symbol |
Group 1 Up-regulation of activators of cell cycle progression | CDCA2, NCAPH, NCAPG, |
Group 2 Loss of genes associated with cellular adhesion and melanocyte differentiation | CDH3, CDH1, PAX3, CITED1 |
Group 3 Up-regulation of genes associated with resistance to apoptosis | BIRC5/Survivin |
New potential gene | Plasmin, TGF-beta1, PLAT, C1 Inhibitor |
Task 5: Result and Discussion
.Global gene expression pattern were obtained using Affymetrix gene chips and comparison of gene expression profiles was performed using hierarchical clustering analysis. This clustering analysis identified two distinct groups of melanoma cell lines based on the similarity of their expression patterns. The first group was characterized as less aggressive primary melanoma and the second group was characterized as more aggressive.